Ishikawa T, Zhu B L, Maeda H
Department of Legal Medicine, Osaka City University Medical School, Asahi-machi 1-4-3, Abeno, Osaka 545-8585, Japan.
Hum Exp Toxicol. 2006 Mar;25(3):135-40. doi: 10.1191/0960327106ht610oa.
Animal experiments are indispensable in the investigation of the toxicity of drugs on cells, but may not be preferred for ethical reasons and sensitivity. As an alternative procedure, we investigated the susceptibility of cells to drugs using the effect on cellular respiration as an indicator of cell activity (toxicity). The primary cultures (cell lines) used in this study included human fetal myocardial cells, skeletal muscle cells, nerve cells, hypophyseal cells, epithelial cells of gastric mucosa, lymphocytes, hepatocytes, pancreatic (exocrine) cells, renal tubular epithelial cells and fetal adrenal cortex cells, which were obtained from the American Type Culture Collection (ATCC). The drugs used were diazepam, haloperidol and levomepromazine maleate (psychoactive drugs), cisplatin and doxorubicin hydrochloride (anticancer agents). The cells were used at a density of 2 x 10(6) cells/2 mL of growth medium and, to test the susceptibility, each drug was prepared at a concentration of 10 g/mL. Experiment results indicated that, even with the same drug, sensitivity was markedly different depending on the cell lines. Cardiac muscle cells showed the strongest respiratory inhibition by Serenace and were least inhibited by Hirnamin. The highest sensitivity to Cercine was noted for neurons, while gastric mucosa cells had almost no sensitivity. Sensitivity to Serenace, which was expected to have a strong nerve action, was higher in myocardial cells instead. In the present study, we suggested the possibility of studying individual differences in drug sensitivity through investigation of toxicity in each organ as opposed to toxicity in the individual. In addition, Serenace, which was developed as a neurotopic agent, showed a higher toxicity in cardiac muscle cells than in neurons. This finding appeared noteworthy, not only for forensic toxicology, but also for clinical practice and drug development.
动物实验在研究药物对细胞的毒性方面不可或缺,但出于伦理原因和敏感性考虑,可能并非首选。作为一种替代方法,我们以细胞呼吸作用作为细胞活性(毒性)指标,研究了细胞对药物的敏感性。本研究中使用的原代培养物(细胞系)包括人胎儿心肌细胞、骨骼肌细胞、神经细胞、垂体细胞、胃黏膜上皮细胞、淋巴细胞、肝细胞、胰腺(外分泌)细胞、肾小管上皮细胞和胎儿肾上腺皮质细胞,这些细胞系购自美国模式培养物集存库(ATCC)。所使用的药物有地西泮、氟哌啶醇和马来酸左美丙嗪(精神活性药物)、顺铂和盐酸多柔比星(抗癌剂)。细胞以2×10⁶个细胞/2 mL生长培养基的密度使用,为测试敏感性,每种药物均配制成10 μg/mL的浓度。实验结果表明,即使是同一种药物,不同细胞系的敏感性也存在显著差异。心肌细胞对舒必利的呼吸抑制作用最强,对海米那的抑制作用最弱。神经元对西仑丁的敏感性最高,而胃黏膜细胞几乎不敏感。预期具有强烈神经作用的舒必利,在心肌细胞中的敏感性反而更高。在本研究中,我们提出通过研究各器官的毒性而非个体的毒性来探讨药物敏感性个体差异的可能性。此外,作为一种神经靶向药物开发的舒必利,在心肌细胞中的毒性高于神经元。这一发现不仅对法医毒理学,而且对临床实践和药物开发都具有重要意义。